MYMylene W. M. Yao

Mylene W. M. Yao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mylene W. M. Yao has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Bokyung Choi

    4 shared publications
  • Denise E. Leong

    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, USA

    4 shared publications
  • Wing H. Wong

    Department of Statistics, School of Humanities and Sciences, Stanford University, Stanford, CA 94305

    3 shared publications
  • Alan Lee

    Department of Obstetrics and Gynecology, School of Medicine, Stanford University, Stanford, California

    2 shared publications
  • Kira Foygel

    Department of Obstetrics and Gynecology, School of Medicine, Stanford University, Stanford, California

    2 shared publications
  • Lynn M. Westphal

    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305

    2 shared publications

Latest Publications

  • Turning Past IVF Data into Personalized Prognostics through a Validated, Multi-Center IVF Prediction Model

    by Bokyung Choi, Kenneth Santo-Domingo, Alan S. Penzias, Ernesto Bosch, Arthur Leader, Antonio Pellicer, Mylene Yao


  • Open Access

    Maternally and zygotically provided Cdx2 have novel and critical roles for early development of the mouse embryo

    by Agnieszka Jedrusik, Alexander W. Bruce, Meng H. Tan, Denise E. Leong, Maria Skamagki, Mylene Yao, Magdalena Zernicka-Goetz


  • Open Access

    Deep phenotyping to predict live birth outcomes in in vitro fertilization

    by Prajna Banerjee, Bokyung Choi, Lora K. Shahine, Sunny H. Jun, Kathleen O’lEary, Ruth B. Lathi, Lynn M. Westphal, Wing H. Wong, Mylene W. M. Yao

    Nearly 75% of in vitro fertilization (IVF) treatments do not result in live births and patients are largely guided by a generalized age-based prognostic stratification. We sought to provide personalized and validated prognosis by using available clinical and embryo data from prior, failed treatments to predict live birth probabilities in the subsequent treatment. We generated a boosted tree model, IVF BT , by training it with IVF outcomes data from 1,676 first cycles (C1s) from 2003–2006, followed by external validation with 634 cycles from 2007–2008, respectively. We tested whether this model could predict the probability of having a live birth in the subsequent treatment (C2). By using nondeterministic methods to identify prognostic factors and their relative nonredundant contribution, we generated a prediction model, IVF BT , that was superior to the age-based control by providing over 1,000-fold improvement to fit new data ( p < 0.05), and increased discrimination by receiver–operative characteristic analysis (area-under-the-curve, 0.80 vs. 0.68 for C1, 0.68 vs. 0.58 for C2). IVF BT provided predictions that were more accurate for ∼83% of C1 and ∼60% of C2 cycles that were out of the range predicted by age. Over half of those patients were reclassified to have higher live birth probabilities. We showed that data from a prior cycle could be used effectively to provide personalized and validated live birth probabilities in a subsequent cycle. Our approach may be replicated and further validated in other IVF clinics.


  • Open Access

    In vitro embryo culture in defined, sub‐microliter volumes

    by Jessica Melin, Alan Lee, Kira Foygel, Denise E. Leong, Stephen R. Quake, Mylene W.M. Yao

    The high attrition rate of in vitro human embryo culture presents a major obstacle in the treatment of clinical infertility by in vitro fertilization (IVF). Physical and genetic requirements are not well understood for human or mouse preimplantation embryo development. Group culture is an established requirement for optimal embryo development in the mouse model. However, conventional microdrop culture limitations hinder investigations of the effects of physical parameters on in vitro embryo development. We report a microfluidics platform that enables embryo culture in precisely defined, sub‐microliter volumes (5–500 nl) which cannot be investigated using conventional methods. Groups of two embryos per microfluidic well successfully developed to the blastocyst stage, at a rate of over 80%, which is comparable to those cultured in 20‐μl microdrops. This system can be used to dissect physical requirements of in vitro single or group embryo culture, and be made highly parallel to increase experimental throughput. Developmental Dynamics 238:950–955, 2009.


  • Open Access

    A Novel and Critical Role for Oct4 as a Regulator of the Maternal-Embryonic Transition

    by Kira Foygel, Bokyung Choi, Sunny Jun, Denise E. Leong, Alan Lee, Connie C. Wong, Elizabeth Zuo, Michael Eckart, Renee A. Reijo Pera, Wing H. Wong, et al.

    Compared to the emerging embryonic stem cell (ESC) gene network, little is known about the dynamic gene network that directs reprogramming in the early embryo. We hypothesized that Oct4, an ESC pluripotency regulator that is also highly expressed at the 1- to 2-cell stages in embryos, may be a critical regulator of the earliest gene network in the embryo. Using antisense morpholino oligonucleotide (MO)-mediated gene knockdown, we show that Oct4 is required for development prior to the blastocyst stage. Specifically, Oct4 has a novel and critical role in regulating genes that encode transcriptional and post-transcriptional regulators as early as the 2-cell stage. Our data suggest that the key function of Oct4 may be to switch the developmental program from one that is predominantly regulated by post-transcriptional control to one that depends on the transcriptional network. Further, we propose to rank candidate genes quantitatively based on the inter-embryo variation in their differential expression in response to Oct4 knockdown. Of over 30 genes analyzed according to this proposed paradigm, Rest and Mta2, both of which have established pluripotency functions in ESCs, were found to be the most tightly regulated by Oct4 at the 2-cell stage. We show that the Oct4-regulated gene set at the 1- to 2-cell stages of early embryo development is large and distinct from its established network in ESCs. Further, our experimental approach can be applied to dissect the gene regulatory network of Oct4 and other pluripotency regulators to deconstruct the dynamic developmental program in the early embryo.


  • Open Access

    Defining Human Embryo Phenotypes by Cohort-Specific Prognostic Factors

    by Sunny H. Jun, Bokyung Choi, Lora Shahine, Lynn M. Westphal, Barry Behr, Renee A. Reijo Pera, Wing H. Wong, Mylene W. M. Yao

    Hundreds of thousands of human embryos are cultured yearly at in vitro fertilization (IVF) centers worldwide, yet the vast majority fail to develop in culture or following transfer to the uterus. However, human embryo phenotypes have not been formally defined, and current criteria for embryo transfer largely focus on characteristics of individual embryos. We hypothesized that embryo cohort-specific variables describing sibling embryos as a group may predict developmental competence as measured by IVF cycle outcomes and serve to define human embryo phenotypes. We retrieved data for all 1117 IVF cycles performed in 2005 at Stanford University Medical Center, and further analyzed clinical data from the 665 fresh IVF, non-donor cycles and their associated 4144 embryos. Thirty variables representing patient characteristics, clinical diagnoses, treatment protocol, and embryo parameters were analyzed in an unbiased manner by regression tree models, based on dichotomous pregnancy outcomes defined by positive serum ß-human chorionic gonadotropin (ß-hCG). IVF cycle outcomes were most accurately predicted at ∼70% by four non-redundant, embryo cohort-specific variables that, remarkably, were more informative than any measures of individual, transferred embryos: Total number of embryos, number of 8-cell embryos, rate (percentage) of cleavage arrest in the cohort and day 3 follicle stimulating hormone (FSH) level. While three of these variables captured the effects of other significant variables, only the rate of cleavage arrest was independent of any known variables. Our findings support defining human embryo phenotypes by non-redundant, prognostic variables that are specific to sibling embryos in a cohort.


  • A Transgenic Mouse Model for High Content, Cell Cycle Phenotype Screening in Live Primary Cells

    by Richard O. Burney, Alan I. Lee, Denise E. Leong, Joshua T. Jones, Angela T. Hahn, Tobias Meyer, Mylene W.M. Yao

    High content cell-based genetic and small molecule library screens are powerful strategies in drug discovery and investigations of disease mechanisms. We report that primary cells derived from a transgenic mouse model expressing a fluorescence mitosis biosensor provide unambiguous phenotype readouts without the need for transfection or immunocytochemistry. Phenotype profiles of cell cycle disruption and of apoptosis are easily detectable at a single time point selected from time-lapse live fluorescence microscopy. Most importantly, this transgenic mouse model may be crossed with cancer mouse models to derive biosensor-expressing primary cancer cells for use in high content screening strategies targeting discovery of tumor-specific chemotherapeutic compounds.